108 related articles for article (PubMed ID: 35378848)
1. Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms.
Jumniensuk C; Nobori A; Lee T; Senaratne TN; Rao D; Pullarkat S
Adv Hematol; 2022; 2022():8091746. PubMed ID: 35378848
[TBL] [Abstract][Full Text] [Related]
2. Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group.
Jansko-Gadermeir B; Leisch M; Gassner FJ; Zaborsky N; Dillinger T; Hutter S; Risch A; Melchardt T; Egle A; Drost M; Larcher-Senn J; Greil R; Pleyer L
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190237
[No Abstract] [Full Text] [Related]
3. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
Northrup V; Maybank A; Carson N; Rahmeh T
Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.
Aguirre-Ruiz P; Ariceta B; Viguria MC; Zudaire MT; Blasco-Iturri Z; Arnedo P; Aguilera-Diaz A; Jauregui A; Mañú A; Prosper F; Mateos MC; Fernández-Mercado M; Larráyoz MJ; Redondo M; Calasanz MJ; Vázquez I; Bandrés E
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255857
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality.
Oliva EN; Latagliata R; Sabattini E; Mammì C; Cuzzola M; D'Errigo MG; Cannatà MC; Bova I; Capodanno I; Palumbo GA; Pane F; Reda G; Fianchi L; Riva M; Poloni A
Am J Blood Res; 2021; 11(4):417-426. PubMed ID: 34540351
[TBL] [Abstract][Full Text] [Related]
7. Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer.
Oh J; Kim YR; Kim Y; Kim B; Park KS; Nam SH; Lee KA
J Cancer; 2021; 12(14):4288-4294. PubMed ID: 34093829
[No Abstract] [Full Text] [Related]
8. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue.
Laquière AE; Lagarde A; Napoléon B; Bourdariat R; Atkinson A; Donatelli G; Pol B; Lecomte L; Curel L; Urena-Campos R; Helbert T; Valantin V; Mithieux F; Buono JP; Grandval P; Olschwang S
World J Gastroenterol; 2019 Sep; 25(36):5530-5542. PubMed ID: 31576098
[TBL] [Abstract][Full Text] [Related]
9. Challenges in next generation sequencing analysis of somatic mutations in transplant patients.
Chen H; Luthra R; Patel KP; Routbort M; Rashid A; Roy-Chowdhuri S; Lazar A; Broaddus R; Manekia J; Singh RR; Yemelyanova A
Cancer Genet; 2018 Oct; 226-227():17-22. PubMed ID: 30005850
[TBL] [Abstract][Full Text] [Related]
10. The Value of T-Cell Receptor γ (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues.
Kansal R; Grody WW; Zhou J; Dong L; Li X
Am J Clin Pathol; 2018 Jul; 150(3):193-223. PubMed ID: 29982316
[TBL] [Abstract][Full Text] [Related]
11. Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections.
Yu J; Diaz JD; Goldstein SC; Patel RD; Varela JC; Reyenga C; Smith M; Smith T; Balls J; Ahmad S; Mori S
Transplant Cell Ther; 2021 Jun; 27(6):500.e1-500.e6. PubMed ID: 33849818
[TBL] [Abstract][Full Text] [Related]
12. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
13. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
[TBL] [Abstract][Full Text] [Related]
14. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies.
Zhang BM; Keegan A; Li P; Lindeman NI; Nagarajan R; Routbort MJ; Vasalos P; Kim AS; Merker JD
Arch Pathol Lab Med; 2021 Sep; 145(9):1110-1116. PubMed ID: 33450747
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
Martin de Frémont G; Hirsch P; Gimenez de Mestral S; Moguelet P; Ditchi Y; Emile JF; Senet P; Georgin-Lavialle S; Hanslik T; Maurier F; Adedjouma A; Abisror N; Mahevas T; Malard F; Adès L; Fenaux P; Fain O; Chasset F; Mekinian A
Front Immunol; 2021; 12():715053. PubMed ID: 34671345
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing for tumor mutation quantification using liquid biopsies.
Provencio M; Pérez-Barrios C; Barquin M; Calvo V; Franco F; Sánchez E; Sánchez R; Marsden D; Cristóbal Sánchez J; Martin Acosta P; Laza-Briviesca R; Cruz-Bermúdez A; Romero A
Clin Chem Lab Med; 2020 Jan; 58(2):306-313. PubMed ID: 31469650
[TBL] [Abstract][Full Text] [Related]
17. Comparative testing of peripheral blood and bone marrow for BCR-ABL transcripts in patients post allogeneic bone marrow transplantation and during interferon treatment for chronic myeloid leukemia.
Kiss TL; Xu WM; Jamal N; Messner HA
Leuk Lymphoma; 1999 Aug; 34(5-6):493-500. PubMed ID: 10492072
[TBL] [Abstract][Full Text] [Related]
18. Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?
Kawata E; Hedley BD; Chin-Yee B; Xenocostas A; Lazo-Langner A; Hsia CC; Howson-Jan K; Yang P; Levy MA; Santos S; Bhai P; Howlett C; Lin H; Kadour M; Sadikovic B; Chin-Yee I
Int J Lab Hematol; 2022 Apr; 44(2):333-341. PubMed ID: 34713980
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS.
Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Gomez Mediavilla A; Urquieta Lam M; Insunza A; Tonda R; Beltran S; Gut M; Gonzalez A; Montes-Moreno S
J Clin Pathol; 2020 Sep; 73(9):571-577. PubMed ID: 31980558
[TBL] [Abstract][Full Text] [Related]
20. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
